Subject(s)
Neoplasm Recurrence, Local/radiotherapy , Postpoliomyelitis Syndrome/complications , Sarcoma, Kaposi/complications , Skin Neoplasms/complications , Aged , Biopsy , Humans , Male , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/radiotherapy , Skin Neoplasms/pathology , Skin Neoplasms/radiotherapySubject(s)
Adalimumab/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Subcutaneous Tissue/pathology , Sweet Syndrome/drug therapy , Sweet Syndrome/pathology , Biopsy, Needle , Chronic Disease , Dose-Response Relationship, Drug , Drug Administration Schedule , Follow-Up Studies , Humans , Immunohistochemistry , Male , Middle Aged , Recurrence , Sweet Syndrome/diagnosis , Treatment OutcomeSubject(s)
Adenocarcinoma/diagnosis , Anti-Infective Agents, Urinary/adverse effects , Cystitis/drug therapy , Lung Diseases, Interstitial/chemically induced , Lung Diseases, Interstitial/diagnosis , Lung Neoplasms/diagnosis , Lung/drug effects , Lung/pathology , Nitrofurantoin/adverse effects , Adenocarcinoma/complications , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Anti-Infective Agents, Urinary/administration & dosage , Carcinoma, Non-Small-Cell Lung/pathology , Chronic Disease , Cough/etiology , Cryptogenic Organizing Pneumonia/diagnosis , Diagnosis, Differential , Dyspnea/etiology , Fatigue/etiology , Female , Humans , Lung Diseases, Interstitial/complications , Lung Diseases, Interstitial/pathology , Lung Neoplasms/complications , Lung Neoplasms/pathology , Middle Aged , Neoplasm Staging , Nitrofurantoin/administration & dosage , Positron-Emission Tomography , Thoracic Surgery, Video-Assisted , Tomography, X-Ray Computed , Weight LossABSTRACT
Peripheral Primitive Neuroectodermal Tumors (PNETs) are rare lesions that arise from outside the central nervous system and normally do not affect the genitourinary system. Primary renal presentations are extremely rare but given their aggressive behavior and characteristic cytomorphologic and genetic features should be considered well-defined distinct clinical entities in order to distinguish them from other primary tumors featuring round cells in the kidney. We report one case of PNET involving the kidney and associated with pregnancy.
ABSTRACT
INTRODUCTION: The occurrence of clear cell tumors in the bladder is not uncommon. Clear cell dysplasia is well-described and characterized by focal replacement of transitional mucosa by cells with abundant clear cytoplasm, nuclear enlargement, and a granular chromatin pattern. Clear cells can also be seen in clear cell adenocarcinoma, which is rare, comprising 0.5% to 2.0% of the reported bladder carcinomas. Other clear cell tumors found in the bladder to be considered in the differential diagnosis are tumors of Müllerian origin and metastatic lesions, such as renal cell carcinoma, clear cell sarcoma, and malignant melanoma. Clear cell urothelial carcinoma is exceedingly rare, with only nine clinical cases described in the literature. CASE PRESENTATION: We report the case of a 75-year-old Caucasian man who presented with intermittent hematuria, in whom a bladder tumor was identified. A final histopathology examination of a cystoprostatectomy specimen revealed a pT3b, G3 urothelial carcinoma of clear cell type (>90% clear cells) and a prostatic adenocarcinoma of Gleason grade 3+3 (score=6). The bladder tumor consisted of sheets of malignant cells with severe nuclear atypia and abundant clear cytoplasm; no glandular or tubular structures were identified. Tumor cells were periodic acid-Schiff positive and negative after diastase treatment; additional mucicarmine and oil red O stains were negative. Immunohistochemical stains showed the tumor cells positive for cytokeratin 7 (CK7), p63 (>80% nuclei), p53 (about 30% nuclei), vimentin, E-cadherin, cluster of differentiation (CD10), and Ki-67 (>70% nuclei). Stains for cell adhesion molecule 5.2 (CAM 5.2), CD117, cytokeratin 20 (CK20), human melanoma black 45 (HMB-45), paired box protein (PAX 8), placental alkaline phosphatase (PLAP), prostate specific antigen (PSA), renal cell carcinoma (RCC), cancer antigen 25 (CA25), leukocyte common antigen (LC), S-100 protein, and uroplakin III were all negative. CONCLUSIONS: The tumor marker profile was consistent with clear cell type carcinoma of urothelial origin. Within the differential diagnoses, we ruled out other possible tumor types such as urothelial carcinoma with focal clear cell differentiation, clear cell adenocarcinoma, Müllerian tumors, and metastatic disease.
Subject(s)
Adenocarcinoma/diagnosis , Carcinoma, Transitional Cell/diagnosis , Prostatic Neoplasms/diagnosis , Urinary Bladder Neoplasms/diagnosis , Adenocarcinoma/complications , Adenocarcinoma/surgery , Aged , Biopsy , Carcinoma, Transitional Cell/complications , Carcinoma, Transitional Cell/surgery , Cystotomy/methods , Diagnosis, Differential , Humans , Male , Prostatectomy/methods , Prostatic Neoplasms/complications , Prostatic Neoplasms/surgery , Urinary Bladder/pathology , Urinary Bladder/surgery , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/surgery , Urothelium/pathology , Urothelium/surgeryABSTRACT
We compared white matter integrity with brain atrophy in healthy controls and participants with very mild dementia (Clinical Dementia Rating 0 vs. 0.5) from the Brain Aging Project, a longitudinal study of aging and memory at the University of Kansas Medical Center. Structural magnetic resonance imaging and diffusion tensor imaging (DTI) including fractional anisotropy and mean diffusivity were performed on 27 patients with very mild dementia (Clinical Dementia Rating = 0.5) of the Alzheimer's type (DAT), and 32 cognitively normal subjects. Patient groups were compared across 6 volumetric measures and 14 DTI regions of interest. Very mildly demented patients showed expected disease-related patterns of brain atrophy with reductions in whole-brain and hippocampal volumes most prominent. DTI indices of white matter integrity were mixed. Right parahippocampus showed significant but small disease-related reductions in fractional anisotropy. Right parahippocampus and left internal capsule showed greater mean diffusivity in early DAT compared with controls. A series of discriminant analyses demonstrated that gray matter atrophy was a significantly better predictor of dementia status than were DTI indices. Brain atrophy was most strongly related to very mild DAT. Modest disease-related white matter anomalies were present in temporal cortex, and deep white matter had limited discriminatory diagnostic power, probably because of the very mild stage of disease in these participants.